Sulpirid (sulpiride) tablets 200 mg. №12

$24.00

Manufacturer: Poland

Purpose: Blocks dopamine receptors; treats schizophrenia, depression, and anxiety.

SKU: MED61506 Categories: ,

Description

Sulpirid (sulpiride) tablets 200 mg. №12

Ingredients

Active ingredient: Sulpiride 200 mg per tablet.

Dosage

Dosage: The usual adult dose is 200-800 mg per day, divided into 2-3 doses. Dosage may vary based on individual needs and medical condition.

Indications

Indications: Sulpiride is indicated for the treatment of schizophrenia and other psychotic disorders.

Contraindications

Contraindications: Do not use Sulpiride if you are allergic to sulpiride or any other ingredients in the tablets. It is contraindicated in patients with pheochromocytoma, severe liver or kidney disease, and certain heart conditions.

Directions

Directions: Take Sulpiride tablets orally with or without food as directed by your healthcare provider. Do not crush or chew the tablets. Follow the dosage instructions carefully.

Scientific Evidence

Sulpiride, a selective dopamine D2 receptor antagonist, has been extensively studied for its efficacy in managing schizophrenia and other psychotic disorders. Research published in the Journal of Clinical Psychopharmacology demonstrated the effectiveness of sulpiride in improving positive and negative symptoms of schizophrenia compared to a placebo.

Additional Information

Sulpiride tablets should be stored at room temperature away from moisture and heat. Keep out of reach of children. It is important to attend regular follow-up appointments with your healthcare provider while taking sulpiride to monitor treatment response and any potential side effects.

Pharmacological Effects: Sulpiride exerts its antipsychotic effects by blocking dopamine receptors in the brain, particularly the D2 receptors. This action helps to regulate dopamine levels and improve symptoms of psychosis.

Clinical Trials: Clinical trials have shown that sulpiride is well-tolerated and effective in managing schizophrenia symptoms. A study published in the Journal of Clinical Psychopharmacology found that sulpiride was associated with significant improvements in both positive and negative symptoms of schizophrenia compared to baseline.